REMAP CAP was too underpowered to show anything or add substantially to the existing evidence base. the reason it’s getting so much press is recency bias. we have a natural tendency to get jazzed up about the newest, hottest trial while ignoring the previous dozens of trials… #1/2 #EMIMCC

Stand Up for Science Burlington, Vermont

If you are now home from #SCCM2025 please considering giving feedback in the app for sessions you particularly liked, or didn’t. Or things you would have liked to see. Next years co-chairs start assembling #SCCM2026 very soon.

#SelfieSunday at #SCCM2025

5 Questions to ask yourself after every patient encounter in the ICU. Outstanding advice and rules to live by from the late Dr JP Pryor. #SCCM2025

How I Do It: Interpreting Clinical Trial Results An excellent rubric for understanding and interpreting randomized clinical trials in #journal_CHESTCritCare: hubs.la/Q030pjgL0 #JournalCHEST

It’s the derivation of this equation (from Josh’s link to the Matzke nonogram paper) which plots vancomycin Cl (ke-1) to CrCL.. Ke=0.00083(CrCL) + 0.0044 Also need to advocate this type of work is a clinical pharmacists bread and butter, and one of the many reasons we need Pharmds at the bedside.

This is a pretty amazing story jamesclaims.substack.com/p/the-hindaw...